# Youjia Bio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/youjia-bio

- Industry: Biotechnology
- Headquarters: Hangzhou, China
- Latest round: Series A (Sep 23, 2022)
- Investors on record: 1

## About

Established in 2019 and based in Hangzhou, China, Youjia (Hangzhou) Biomedical Technology Co., Ltd is a biomedicine company that focuses on research and development of nucleic acid drug. In 2022, the company raised an undisclosed amount of series A+ funding led by new investor Shanxi Growth Enterprise Leading Fund.


The company's self-developed nucleic acid drug development platform includes a nucleic acid drug intelligent design NDDS (Novel Drug Delivery Systems) system, a mature delivery system, a complete drug evaluation platform and a polymer based multi-dose formulation platform. The products are used in the field of anti-virus, anti-fibrosis and cardiovascular disease.

## Funding rounds

- Series A, Sep 23, 2022 — Shanxi Growth Enterprise Leading Fund

## Investors

- Shanxi Growth Enterprise Leading Fund (https://capitalatlas.ai/funds/shanxi-growth-enterprise-leading-fund) — Series A